0001836461-20-000001.txt : 20201215 0001836461-20-000001.hdr.sgml : 20201215 20201215151027 ACCESSION NUMBER: 0001836461-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20201215 DATE AS OF CHANGE: 20201215 EFFECTIVENESS DATE: 20201215 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Resilient Biotics, Inc. CENTRAL INDEX KEY: 0001836461 IRS NUMBER: 814591350 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-383270 FILM NUMBER: 201389413 BUSINESS ADDRESS: STREET 1: 2 DAVIS DRIVE CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 BUSINESS PHONE: 717-350-3133 MAIL ADDRESS: STREET 1: 2 DAVIS DRIVE CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 D 1 primary_doc.xml X0708 D LIVE 0001836461 Resilient Biotics, Inc. 2 DAVIS DRIVE RESEARCH TRIANGLE PARK NC NORTH CAROLINA 27709 717-350-3133 DELAWARE None None Corporation true 2016 Christopher Belnap 2 Davis Drive Durham NC NORTH CAROLINA 27709 Executive Officer Director Greg Werner 2 Davis Drive Durham NC NORTH CAROLINA 27709 Executive Officer Director John Peryam 2 Davis Drive Durham NC NORTH CAROLINA 27709 Director Eric Eason 2 Davis Drive Durham NC NORTH CAROLINA 27709 Director Biotechnology Decline to Disclose 06b false 2020-12-02 false true false 0 7172432 7172432 0 false 18 0 0 0 true Proceeds will be used for working capital, which may include normal compensation to executive officers. false Resilient Biotics, Inc. Christopher Belnap Christopher Belnap CEO 2020-12-09